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Case report
  A 40-year-old female presented to the emergency de-
partment at an outside facility with symptoms of  vaginal 
bleeding, abdominal pain, headaches, dizziness, double 
vision, and epistaxis. The patient had been experiencing 
heavy vaginal bleeding with abdominal pain for a period of 
several months after a normal C-section delivery of  a 
healthy female infant. Her placental pathology revealed a 
small nodular placental lesion consistent with trophoblastic 
disease (Fig. 1).
She was seen postoperatively in the clinic; however, there 
was no workup at that time, as her visit was prior to the 
reporting of  the pathology results. In the interim, she was 
seen at multiple emergency departments for persistent 
vaginal bleeding and abdominal pain, with diagnoses of  
spontaneous abortion with retained products of  concep-
tion. She was administered misoprostol for evacuation with 
plans for followup in the clinic with beta-hCG levels; how-
ever, she was again lost to followup. During her most recent 
visit to an outside emergency department, her beta-hCG 
was 225,000 mIU/ml, and a pelvic ultrasound revealed 
pelvic free fluid, but no intrauterine pregnancy or abdomi-
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Fig. l. Placental pathology revealed a small (2.5 cm x 2.0 
cm x 2.0 cm) nodular placental lesion consistent with tro-
phoblastic disease. Choriocarcinoma is characterized by 
abnormal trophoblastic hyperplasia and anaplasia (black 
arrows), absence of chorionic villi, hemorrhage, necrosis 
(white arrows), and direct invasion into the myometrium. 
(H&E stain, 100x magnification)
nal masses. Due to high suspicion for an ectopic pregnancy, 
she was taken to the operating room for a diagnostic lapa-
roscopy, which revealed a small hematoma in the retroperi-
toneum, but no etopic pregnancy. She required multiple 
blood transfusions, as her hemoglobin had dropped from 
11 to 7 g/dL. She also underwent diagnostic CT scans of  
the chest, abdomen, and pelvis that revealed a right-upper-
lobe pulmonary lesion, bilateral renal lesions, and an asso-
ciated left-sided retroperitoneal hematoma (Fig. 2). 
Due to concern for malignant gestational trophoblastic 
disease with hemorrhage, the patient was transferred to our 
institution for a higher level of  care. She was admitted to 
the gynecologic-oncology service for further workup and 
treatment. A pelvic ultrasound revealed no intrauterine 
pregnancy, no focal mass lesions, normal adnexa, and a 
thickened endometrium measuring up to 2 cm with a small 
amount of  flow. As part of  the metastatic workup, the pa-
tient underwent a head CT scan that revealed a 4-mm 
contrast-enhancing focus in the left parietal lobe. A subse-
quent MRI demonstrated the solitary lesion, with no other 
intracranial metastases identified (Fig. 3). A diagnosis of  
metastatic gestational trophoblastic neoplasm was made 
with a WHO score of  14, or Stage IV disease, with renal 
and brain metastases. The patient was started on induction 
chemotherapy with etoposide and cisplatin, plus whole 
brain radiation, and was subsequently discharged. 
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Fig. 3. A head CT scan revealed a 4-mm contrast-
enhancing focus in the left parietal lobe (a, b). Subsequent 
MRI demonstrated the solitary lesion (c, d). A susceptibility-
weighted sequence (e) revealed that the lesion was associ-
ated with hemorrhage, further raising concern for metastatic 
choriocarcinoma. No other intracranial metastases were 
identified. 
Fig. 2. Diagnostic CT scan of the chest (a, b) revealed a 
bilobed right-upper-lobe pulmonary lesion measuring 1.4 
cm AP x 2.1 cm TV x 1.8 cm CC. Lungs are the most com-
mon site of metastasis for choriocarcinoma, accounting for 
76%-87% of metastases, and it is rare to have additional 
metastatic sites in the absence of lung metastases. CT 
scan of the abdomen also demonstrated bilateral contrast-
enhancing renal lesions measuring 2.7 cm AP x 2.6 cm TV 
x 3.5 cm CC in the right upper pole (c, d) and 2.7 cm AP x 
2.4 cm TV x 4.2 cm CC in the left lower pole (e, f). The left 
renal lesion was also associated with a large retroperito-
neal hematoma measuring approximately 22 cm in CC di-
mension. Choriocarcinoma is a hypervascular tumor and is 
often associated with bleeding; as a result, biopsy of meta-
static lesions is not routinely performed, as it may result in 
excessive bleeding.
Unfortunately, the patient represented to the emergency 
department two days later with symptoms of  nausea, vom-
iting, severe abdominal pain radiating to the left flank, and 
weakness. Her hemoglobin had dropped from 10.0 g/dL 
on discharge to 8.4 g/dL on readmission to the emergency 
department. An abdomen/pelvis CT scan revealed in-
creased size of  the large left retroperitoneal hematoma and 
interval development of  a new retroperitoneal hematoma 
(Fig. 4). The patient was readmitted to the gynecologic-
oncology service. Due to concern for active bleeding, inter-
ventional radiology was consulted for possible emboliza-
tion. After bilateral renal arteriography, however, no active 
extravasation or hypervascular tumors were identified, and 
embolization could not be performed. The patient was 
managed supportively and remained hemodynamically 
stable during the subsequent course of  her hospitalization 
and discharged home with a plan to continue on an EMA/
CO (etoposide, methotrexate, actinomycin D, 
cyclophosphamide, vincristine/oncovine) 
chemotherapy regimen, and whole brain 
radiation. 
Discussion
 Gestational trophoblastic disease (GTD) in-
cludes a spectrum of  abnormalities arising 
from the placental villous trophoblast and 
consists of  four main types: hydatidiform 
mole, invasive mole, placental site trophoblas-
tic tumor (PSTT), and choriocarcinoma. Ges-
tational trophoblastic neoplasia (GTN) implies 
metastatic potential, and refers to the latter 
three abnormalities, which have a high mor-
tality rate if  untreated. Prior to chemotherapy, 
invasive moles carried a mortality rate of  ap-
proximately 15%, and choriocarcinoma re-
sulted in a mortality rate of  almost 100%. 
The outcomes of  GTN improved drastically 
after the introduction of  chemotherapy, with 
cure rates of  greater than 90% (1-4). 
There is limited data regarding the incidence 
of  choriocarcinoma due to its rarity and chal-
lenging clinical distinction from invasive mole. 
Choriocarcinoma has an incidence of  approximately 1 in 
40,000 pregnancies in Europe and North America, and a 
higher incidence in Southeast Asia and Japan of  approxi-
mately 9.2 and 3.3 in 40,000 pregnancies. Incidence rates 
for both hydatidiform mole and choriocarcinoma have 
declined over the latter part of  the 21st century (5, 6). 
Pathologically, choriocarcinoma is characterized by ab-
normal trophoblastic hyperplasia and anaplasia, absence of 
chorionic villi, hemorrhage, necrosis, and direct invasion 
into the myometrium (Fig. 1) (1, 7). Vascular invasion (he-
matogenous spread) results in distant metastases that most 
commonly include the lungs (76%-87%), vagina (30%), 
brain (10%), liver (10%), pelvis, kidney, intestines, and 
spleen, although metastases have been reported in virtually 
every body site (8). It is rare, however, to have additional 
metastatic sites in the absence of  lung metastases (9). Vagi-
nal metastases are an exception, as spread is contiguous 
rather than hematogenous (10). Although metastatic dis-
ease has been reported in up to 19% of  all GTN, chorio-
carcinoma accounts for the majority of  cases (9). Central 
nervous system metastases may produce neurologic symp-
toms, intracranial hemorrhage, or mass lesions. Biopsy is 
rarely necessary and may result in excessive bleeding, with 
serum beta-hCG and exclusion of  pregnancy being the 
main diagnostic criteria required for GTN in the presence 
of  metastases (11-13).
Ultrasound is the imaging study of  choice for the initial 
diagnosis of  GTN. In addition to identifying a molar preg-
nancy, ultrasound is primarily used to exclude an intrauter-
ine pregnancy before initiation of  chemotherapy. Although 
transvaginal ultrasound results in greater resolution and 
can potentially demonstrate more findings, it is not rou-
tinely done at all centers due to the risk of  bleeding from 
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Fig. 4. An abdomen/pelvis CT scan was performed after the 
patient represented to the emergency department two days 
after discharge with symptoms of nausea, vomiting, severe 
abdominal pain radiating to the left flank, weakness, and a 
hemoglobin drop from 10.0 g/dL on discharge to 8.4 g/dL 
on readmission. Imaging revealed interval development of 
a right-sided subcapsular hematoma extending from the 
previously visualized right renal lesion (a, b) and interval 
increased size of the large left renal mass (c, d), now 
measuring approximately 5.2 cm AP x 3.7 cm TV x 5.3 cm 
CC, with interval increase in associated retroperitoneal 
hematoma now measuring 27 cm in CC dimension. The 
patient was subsequently taken to interventional radiology 
for possible embolization; however, renal arteriography did 
not reveal a hypervascular lesion or active extravasation.
possible vaginal metastases. Choriocarcinoma is markedly 
hypervascular on Doppler ultrasonography; however, en-
dometrial, myometrial, and parametrial invasion can be 
difficult to demonstrate (9). 
Magnetic resonance imaging (MRI) of  the pelvis can be 
helpful in such cases, but it is seldom clinically indicated in 
the routine assessment of  GTN and is typically used in 
challenging cases such as relapsed patients, suspected 
PSTT, or very advanced disease. MRI of  the brain, how-
ever, is recommended for staging, especially in the presence 
of  lung metastases and neurologic symptoms, as these pa-
tients are at significant risk for CNS metastases (9, 14, 15). 
Although a chest radiograph is recommended as the ini-
tial radiographic staging for patients with malignant GTN, 
a computed tomography scan (CT) is more routinely per-
formed, as approximately 41% of  patients have lung metas-
tases that are not detected on plan radiograph (16). 
Contrast-enhanced CT is the diagnostic modality of  choice 
for the assessment of  metastatic disease, as choriocarci-
noma is characteristically hypervascular and tends to bleed 
(8, 9). 
As with our patient, choriocarcinoma can be complicated 
by hemorrhage from the tumor itself  or from vascular mal-
formations. GTN is the most common cause of  uterine 
vascular malformations, and when hemorrhage occurs as a 
complication, the lesions are amenable to endovascular 
management, as these lesions are supplied by the uterine 
arteries (17).  Our case, however, resulted in a negative bi-
lateral renal arteriography, which precluded embolization 
of  a self-resolved retroperitoneal bleed. 
 In summary, choriocarcinoma is a challenging diagnosis 
to make during a single presentation. Prolonged menor-
rhagia and markedly elevated beta-hCG should raise suspi-
cion for choriocarcinoma and prompt further workup, es-
pecially in the setting of  neurologic symptoms. Choriocar-
cinoma accounts for the majority of  metastatic GTN and 
predominantly demonstrates hematogenous spread. Most 
common sites of  hematogenous metastases include lungs, 
brain, liver, pelvis, and kidneys. Vaginal metastases are also 
common and occur via contiguous spread. Biopsy is rarely 
necessary for diagnosis and can result in excessive bleeding. 
Urgent specialist consultation with induction of  chemo-
therapy can significantly improve prognosis.
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